Low-dose naltrexone for different types of vulvodynia pain
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This Phase 2 study tests whether low-dose naltrexone can reduce pain from vulvodynia. It also looks at how well it works across different vulvodynia types, comparing to what participants are already doing for symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 up to menopause or up to age 50
- You are not pregnant and you won’t try to become pregnant for the next 9 months
- You must sign consent and be generally healthy (WHO score 0–2)
- You have a diagnosis of vulvodynia and can confirm it at study screening
- You can’t be taking opioid pain medicines in the last 2 months
- You must use strong birth control during the study (no abstinence instead)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study looks at how opioids affect your experience of social situations and your brain activity. It may help researchers understand how opioid medicines influence social perception and brain signaling.
This trial studies whether a low dose of naltrexone can reduce long-lasting nerve-related pain in adults living with HIV. It may help if your pain has been ongoing and you have stable HIV control.
This Phase 2 trial studies whether a low dose of naltrexone can reduce painful nerve pain caused by diabetes. It may help people whose diabetic nerve pain did not improve with at least one standard treatment.
This trial tests whether a low dose of naltrexone, a medication that may help calm overactive immune and pain signals, can reduce pain and improve daily life in people with complex regional pain syndrome (CRPS), a chronic condition that often causes severe pain and swelling.
This trial tests whether low-dose naltrexone can reduce symptoms of complex regional pain syndrome (CRPS), a long-lasting pain condition in an arm or leg. It may help by targeting pain signaling, but you must meet specific CRPS diagnosis and medication rules to join.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
Hear when a new Vulvodynia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.